Literature DB >> 23807706

Distribution of voltage-dependent and intracellular Ca2+ channels in submucosal neurons from rat distal colon.

Matthias Rehn1, Sandra Bader, Anna Bell, Martin Diener.   

Abstract

We recently observed a bradykinin-induced increase in the cytosolic Ca2+ concentration in submucosal neurons of rat colon, an increase inhibited by blockers of voltage-dependent Ca2+ (Ca(v)) channels. As the types of Ca(v) channels used by this part of the enteric nervous system are unknown, the expression of various Ca(v) subunits has been investigated in whole-mount submucosal preparations by immunohistochemistry. Submucosal neurons, identified by a neuronal marker (microtubule-associated protein 2), are immunoreactive for Ca(v)1.2, Ca(v)1.3 and Ca(v)2.2, expression being confirmed by reverse transcription plus the polymerase chain reaction. These data agree with previous observations that the inhibition of L- and N-type Ca2+ currents strongly inhibits the response to bradykinin. However, whole-cell patch-clamp experiments have revealed that bradykinin does not enhance Ca2+ inward currents under voltage-clamp conditions. Consequently, bradykinin does not directly interact with Ca(v) channels. Instead, the kinin-induced Ca2+ influx is caused indirectly by the membrane depolarization evoked by this peptide. As intracellular Ca2+ channels on Ca(2+)-storing organelles can also contribute to Ca2+ signaling, their expression has been investigated by imaging experiments and immunohistochemistry. Inositol 1,4,5-trisphosphate (IP3) receptors (IP3R) have been functionally demonstrated in submucosal neurons loaded with the Ca(2+)-sensitive fluorescent dye, fura-2. Histamine, a typical agonist coupled to the phospholipase C pathway, induces an increase in the fura-2 signal ratio, which is suppressed by 2-aminophenylborate, a blocker of IP3 receptors. The expression of IP3R1 has been confirmed by immunohistochemistry. In contrast, ryanodine, tested over a wide concentration range, evokes no increase in the cytosolic Ca2+ concentration nor is there immunohistochemical evidence for the expression of ryanodine receptors in these neurons. Thus, rat submucosal neurons are equipped with various types of high-voltage activated Ca(v) channels and with IP3 receptors for intracellular Ca2+ signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807706     DOI: 10.1007/s00441-013-1643-5

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  5 in total

1.  Potential association between ITPKC genetic variations and Hirschsprung disease.

Authors:  Jeong-Hyun Kim; Soo-Min Jung; Joong-Gon Shin; Hyun Sub Cheong; Jeong-Meen Seo; Dae-Yeon Kim; Jung-Tak Oh; Hyun-Young Kim; Kyuwhan Jung; Hyoung Doo Shin
Journal:  Mol Biol Rep       Date:  2017-06-29       Impact factor: 2.316

2.  Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva).

Authors:  W Zhong; S Chebolu; N A Darmani
Journal:  Neurochem Int       Date:  2018-11-16       Impact factor: 3.921

3.  Deletion of IP3R1 by Pdgfrb-Cre in mice results in intestinal pseudo-obstruction and lethality.

Authors:  Hong Wang; Ran Jing; Christa Trexler; Yali Li; Huayuan Tang; Zhixiang Pan; Siting Zhu; Beili Zhao; Xi Fang; Jie Liu; Ju Chen; Kunfu Ouyang
Journal:  J Gastroenterol       Date:  2018-10-31       Impact factor: 7.527

4.  Intracellular emetic signaling evoked by the L-type Ca2+ channel agonist FPL64176 in the least shrew (Cryptotis parva).

Authors:  Weixia Zhong; Seetha Chebolu; Nissar A Darmani
Journal:  Eur J Pharmacol       Date:  2018-06-30       Impact factor: 4.432

5.  Functional expression of bradykinin B1 and B2 receptors in neonatal rat trigeminal ganglion neurons.

Authors:  Aya Kawaguchi; Masaki Sato; Maki Kimura; Takaki Yamazaki; Hitoshi Yamamoto; Masakazu Tazaki; Tatsuya Ichinohe; Yoshiyuki Shibukawa
Journal:  Front Cell Neurosci       Date:  2015-06-15       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.